Dynamic regulation of hypoxia-inducible factor-1α activity is essential for normal B cell development

Journal: Nature Immunology

Published: 2020-08-31

DOI: 10.1038/s41590-020-0772-8

Affiliations: 17

Authors: 22

Go to article
Institutions Share
Department of Medicine, University of Cambridge, United Kingdom (UK) 0.23
Cambridge Institute for Medical Research (CIMR), University of Cambridge, United Kingdom (UK) 0.14
European Bioinformatics Institute (EMBL-EBI), United Kingdom (UK) 0.09
Molecular Immunity Unit, University of Cambridge, United Kingdom (UK) 0.08
Cambridge Institute of Therapeutic Immunology and Infectious Diseases (CITIID), University of Cambridge, United Kingdom (UK) 0.07
Alloimmunité-Autoimmunité-Transplantation (A2T), France 0.07
MRC Laboratory of Molecular Biology (LMB), United Kingdom (UK) 0.05
Oxford Wellcome Trust Centre for Human Genetics, United Kingdom (UK) 0.05
MRC Human Immunology Unit (HIU), United Kingdom (UK) 0.05
Department of Haematology, University of Cambridge, United Kingdom (UK) 0.05
Wellcome Trust - MRC Cambridge Stem Cell Institute, University of Cambridge, United Kingdom (UK) 0.04
Royal Free Hospital, United Kingdom (UK) 0.03
Oxford Kidney Unit, OUH, United Kingdom (UK) 0.02
Churchill Hospital, United Kingdom (UK) 0.02
Sanger Institute Cellular Genetics Programme, United Kingdom (UK) 0.02
UCL Division of Surgery and Interventional Science, United Kingdom (UK) 0.02

Return

Except where otherwise noted © 2021 Springer Nature Limited. All Rights Reserved.
partner of AGORA, HINARI, OARE, INASP, ORCID, CrossRef and COUNTER